安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- SCC Soft Computer is Proud to Announce the Development of the SoftBank . . .
In collaboration with industry experts, SCC Soft Computer is developing an interface directly to the Alloantibody Exchange, with the goal to increase transfusion safety by improving shared patient antibody information between various facilities
- Our Response to COVID-19 | SoftBank Group Corp.
SoftBank Group Corp established Coronavirus Inspection Center Corp (currently SB Coronavirus Inspection Center Corp ) in July 2020, with the aim of preventing the spread of COVID-19 infections and achieving an early normalization of economic activity
- Lessons Learned Interfacing SoftBank to Foreign LIS - SNUG
Standalone SoftBank The popularity and advanced features of SoftBank have led to many organizations adding SoftBank as a module or replacing their current Blood Bank module without changing the LIS system Unique constraints exist when SoftBank is interfaced with a Foreign LIS system
- SoftBank says it tested 44,000 people for Covid-19 antibodies . . . - CNN
Japanese tech conglomerate SoftBank just conducted voluntary Covid-19 antibody tests on more than 44,000 employees, their families, clients and outside medical professionals such as doctors and
- Antibody panels - Abcam
Antibody panels are sets of antibodies in smaller pack sizes that enable you to assess how various antibodies perform in your experiment We have curated our antibody panels to offer high-quality, well-validated antibodies for multiple targets in a cost-effective and efficient format
- SoftBank conducts 44,000 antibody tests; 0. 43% come back positive
TOKYO -- SoftBank Group on Tuesday revealed the results of 44,066 coronavirus antibody tests conducted on its employees and their families as well as Tech conglomerate leads Japan's largest
- SoftBank test says 0. 43% of 44,000 have coronavirus antibody in Japan
SoftBank Group Corp said Tuesday that 0 43 percent, or 191, of 44,066 blood samples collected from its employees, medical workers and others in Japan had antibodies for the new coronavirus
- Simulated red cell antibody identification training panels created . . .
We evaluated the feasibility of SARS-CoV-2 peptide modified RBCs (1144-kodecytes) to develop simulated antibody screening and identifica-tion panels of reagent RBCs suitable for practical training, recognition, and grading of serologic reactions
|
|
|